ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
1 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
53
|
30K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
5 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
53
|
30K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
5 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
53
|
30K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
7 |
19/01/20 |
19/01/20 |
ASX - By Stock
|
53
|
30K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
10 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
53
|
30K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
3 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
53
|
30K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen at SACHS Forum and JP Morgan week
|
|
Stungun
|
53 |
30K |
5 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
53
|
30K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2019 and outlook
|
|
Stungun
|
95 |
38K |
4 |
31/12/19 |
31/12/19 |
ASX - By Stock
|
95
|
38K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2019 and outlook
|
|
Stungun
|
95 |
38K |
4 |
29/12/19 |
29/12/19 |
ASX - By Stock
|
95
|
38K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2019 and outlook
|
|
Stungun
|
95 |
38K |
3 |
23/12/19 |
23/12/19 |
ASX - By Stock
|
95
|
38K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2019 and outlook
|
|
Stungun
|
95 |
38K |
2 |
23/12/19 |
23/12/19 |
ASX - By Stock
|
95
|
38K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2019 and outlook
|
|
Stungun
|
95 |
38K |
11 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
95
|
38K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Managing Director's AGM Presentation
|
|
Stungun
|
89 |
33K |
1 |
08/12/19 |
08/12/19 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Managing Director's AGM Presentation
|
|
Stungun
|
89 |
33K |
6 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
89
|
33K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Managing Director's AGM Presentation
|
|
Stungun
|
89 |
33K |
4 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
89
|
33K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
Stungun
|
210 |
84K |
9 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
210
|
84K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
The Science Behind Actinogen
|
|
Stungun
|
60 |
33K |
5 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
60
|
33K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
Stungun
|
210 |
84K |
2 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
210
|
84K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
Stungun
|
210 |
84K |
5 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
210
|
84K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
Stungun
|
210 |
84K |
10 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
210
|
84K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
@US10 silence since XanaHES announcement
|
|
Stungun
|
210 |
84K |
2 |
05/11/19 |
05/11/19 |
ASX - By Stock
|
210
|
84K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: R&D Tax Incentive rebate received of $4.58 million
|
|
Stungun
|
201 |
57K |
2 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
201
|
57K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Stungun
|
4 |
3.2K |
1 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
4
|
3.2K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Well-timed XanaHES study saves the day
|
|
Stungun
|
131 |
43K |
1 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
131
|
43K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Holy grail found
|
|
Stungun
|
88 |
39K |
2 |
12/10/19 |
12/10/19 |
ASX - By Stock
|
88
|
39K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
5 |
11/10/19 |
11/10/19 |
ASX - By Stock
|
582
|
247K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
6 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
582
|
247K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
1 |
06/10/19 |
06/10/19 |
ASX - By Stock
|
582
|
247K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
RE-HASH of Xanamen Trials from 2013
|
|
Stungun
|
35 |
14K |
2 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
RE-HASH of Xanamen Trials from 2013
|
|
Stungun
|
35 |
14K |
3 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
35
|
14K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
RE-HASH of Xanamen Trials from 2013
|
|
Stungun
|
35 |
14K |
6 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
35
|
14K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
7 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
582
|
247K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
8 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
582
|
247K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
4 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
582
|
247K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
3 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
582
|
247K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
1 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
582
|
247K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Cognitive improvement demonstrated with Xanamem
|
|
Stungun
|
582 |
247K |
4 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
582
|
247K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Medical Conference Call
|
|
Stungun
|
35 |
9.5K |
1 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
35
|
9.5K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
Stungun
|
72 |
27K |
5 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
72
|
27K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
Stungun
|
72 |
27K |
5 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
72
|
27K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
3 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
49
|
34K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
1 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
49
|
34K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
10 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
49
|
34K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
5 |
14/09/19 |
14/09/19 |
ASX - By Stock
|
49
|
34K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
2 |
04/09/19 |
04/09/19 |
ASX - By Stock
|
49
|
34K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
3 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
49
|
34K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
4 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
49
|
34K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
2 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
49
|
34K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4E & Annual Report
|
|
Stungun
|
49 |
34K |
2 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
49
|
34K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Clinical Development and Scientific Conference Update
|
|
Stungun
|
70 |
32K |
5 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
70
|
32K
|
5
|
|